Atherosclerosis remains a major contributor to cardiovascular disease worldwide, creating a sustained need for effective medicines that can prevent disease progression, reduce plaque accumulation, and lower the risk of serious cardiovascular events. The condition develops when cholesterol, fats, inflammatory cells, and other substances accumulate within arterial walls, gradually narrowing the arteries and restricting blood flow. If left unmanaged, it can lead to coronary artery disease, heart attacks, strokes, and peripheral artery disease.